Alterity Therapeutics (ATHE) Change in Account Payables (2009 - 2020)

Alterity Therapeutics' Change in Account Payables history runs 11 years deep, the most recent figure standing at -$425086.2 for Q2 2020.

• In Q2 2020, Change in Account Payables fell 191.54% year-over-year to -$425086.2; the TTM figure through Jun 2020 stood at -$309780.3 (down 55.35% YoY), while the FY2025 annual figure was -$1.3 million, down 280.25% from the prior year.
• Change in Account Payables for Q2 2020 stood at -$425086.2, down from $64066.7 in the prior quarter.
• The five-year high for Change in Account Payables was $464361.3 in Q2 2019, with the low at -$643134.5 in Q2 2017.
• The 5-year median for Change in Account Payables is -$278480.6 (2016), against an average of -$198144.3.
• The sharpest annual moves came in 2019 and 2020: Change in Account Payables jumped 5175.08% in 2019, then slumped 191.54% in 2020.
• Alterity Therapeutics' Change in Account Payables stood at -$278480.6 in 2016, then grew by 6.83% to -$259449.8 in 2017, then sank by 59.23% to -$413122.1 in 2018, then surged by 115.51% to $64066.7 in 2019, then tumbled by 763.51% to -$425086.2 in 2020.
• Business Quant data shows ATHE's Change in Account Payables at -$425086.2 in Q2 2020, $64066.7 in Q4 2019, and $464361.3 in Q2 2019.